SCHEMBL5486043

SCHEMBL5486043

Cc1c(Cl)cc(Cl)cc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
HSD11B1 P28845 2/20 0.44
CSNK2A1 P68400 2/20 0.43
METAP2 P50579 1/20 0.42
SQOR Q9Y6N5 1/20 0.41
ACLY P53396 2/20 0.40
CYP1A2 P05177 2/20 0.39
PTGS1 P23219 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ESR2 Q92731 1/20 0.38
BACE1 P56817 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28598819 0.83 CYP2A6 (0.46) CYP2A6HSD11B1CSNK2A1METAP2SQOR
SCHEMBL29473772 0.83 CYP2A6 (0.46) CYP2A6HSD11B1CSNK2A1METAP2SQOR
SCHEMBL11317813 0.82 ALDH1A1 (0.39) HSD11B1ALDH1A1HPGDTSHRHSD17B10
SCHEMBL2140618 0.78 CYP2A6 (0.50) CYP2A6HSD11B1CSNK2A1METAP2ACLY
SCHEMBL21600237 0.76 CYP2A6 (0.46) CYP2A6CSNK2A1METAP2ACLYCYP1A2
SCHEMBL27900205 0.75 CYP2A6 (0.46) CYP2A6HSD11B1CSNK2A1SQORCYP1A2
SCHEMBL10715265 0.75 CYP2A6 (0.46) CYP2A6HSD11B1CSNK2A1SQORCYP1A2
SCHEMBL29674520 0.75 CYP2A6 (0.46) CYP2A6HSD11B1CSNK2A1METAP2ACLY
SCHEMBL2810864 0.75 ALDH1A1 (0.52) CYP2A6ACLYALDH1A1TSHRHSD17B10
SCHEMBL25369445 0.75 CYP2A6 (0.50) CYP2A6CSNK2A1METAP2CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7227027-B2 Carbazole derivative and its use in electroluminescent devices TSINGHUA UNIVERSITY (CH) 2007-06-05 US disclosed
US-20050127826-A1 Carbazole derivative and its use in electroluminescent devices BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050127826-A1 Carbazole derivative and its use in electroluminescent devices OCIAD1, OCIAD2, EED CYP2A6 3812/4885HSD11B1 1920/4885CSNK2A1 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.